HilleVax’s stock craters after biotech says it’s scrapping a norovirus vaccine for infants after a failed trial

by | Jul 8, 2024 | Stock Market

HilleVax Inc.’s stock cratered 89% early Monday, after the biotech said it would discontinue development of a vaccine against norovirus for infants after a trial missed its main goals.

Article Attribution | Read More at Article Source

[mwai_chat context=”Let’s have a discussion about this article:nnHilleVax Inc.’s stock cratered 89% early Monday, after the biotech said it would discontinue development of a vaccine against norovirus for infants after a trial missed its main goals.nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
Share This